Drug Profile
Research programme: ammonium tetrathiomolybdate injection - Magnus Life Science
Alternative Names: Injectable therapy - Magnus Oxygen; Reperfusion injury therapeutic - Magnus Oxygen; TTM injection - Magnus OxygenLatest Information Update: 27 Mar 2023
Price :
$50
*
At a glance
- Originator Magnus Life Science; University College London
- Class Heavy metals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chronic heart failure; Myocardial infarction; Reperfusion injury; Stroke
Most Recent Events
- 27 Mar 2023 Discontinued - Preclinical for Chronic heart failure (Prevention) in United Kingdom (Injection)
- 27 Mar 2023 Discontinued - Preclinical for Myocardial infarction (Prevention) in United Kingdom (Injection)
- 27 Mar 2023 Discontinued for Reperfusion injury in United Kingdom (Injection)